Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Fred Hutch Antibody Technology lab is recognized internationally as a one of the most technically advanced academic groups in monoclonal antibody discovery. In addition to developing diagnostic and therapeutic antibodies for Fred Hutch research programs, the team coordinates external collaborations with academic and industrial clients on approximately 40 novel antibody discovery campaigns annually. Over the past four years the lab has integrated over $2.5M in laboratory automation and high-throughput screening technology for monoclonal antibody discovery.
The team is currently seeking a highly motivated individual to fill a Research Technician I or II position depending on years of education and experience. The position may be ideal for a recent BA/BS, MA, or PhD graduate seeking unique experience in high-throughput screening of biologics, laboratory automation, and molecular engineering of antibody compositions for potential diagnostics and therapeutics. The ability to work independently on multiple projects simultaneously is essential.
Specific responsibilities include:
Scheduling and tracking multiple projects.
Comfortable working with and programming complex automated instrumentation.
Molecular biology knowledge is essential and experience desired.
Comfortable with IACUC approved use of mice, rats, and rabbits for the generation of novel antibody compositions. Experience with handling mice a plus.
The successful candidate must be highly motivated, reliable, and independently productive with a BA/BS, MS, or PhD degree in a scientific discipline (biology, chemistry, engineering, or computer science). Some hands-on laboratory experience is preferred but is not essential as the work is specialized. Knowledge of specialized software applications (Tecan EVOWare , ClonePix Fusion , IntelliCyt ForeCyt, UNICORN , Thermo Momentum , Geneious , Liquid Planner ) is a plus, however having a strong interest to master these applications is essential.
Please include a cover letter with your application, detailing your interest and suitability for this position.
We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.